Substandard and Falsified Medicines (FIND)

The presence of Substandard and Falsified (SF) medical products in countries, and their use by patients, impacts our ability to effectively tackle antimicrobial resistance (AMR). We need to investigate this use both to understand the true scale of AMR as well as how much SF medicines may be contributing to the growing resistance.

The Fleming Fund is supporting the Foundation of Innovative and New Diagnostics (FIND’s) work to increase the ability of low- and middle-income countries (LMICs) to detect and respond to SF medicines by evaluating the effectiveness of three field-based screening technologies, enabling LMICs to authenticate a medicine or establish whether it is SF without relying completely on central lab facilities which many LMICs do not have ready access to.

FIND (Foundation for Innovative New Diagnostics)

2.5 years (May 2018 - September 2020)


Initial pilot in Laos



Other grants

Global Projects › Sierra Leone | Ghana | Nigeria | Uganda | Tanzania | Malawi | Bangladesh

Substandard and Falsified Medicines (WHO)